Cap Innov'Est is a closed private equity fund managed by Alsace Capital.
PeptiMimesis, a France-based biopharma company, closed a €0.5m first tranche of a €1.2m funding round led by Cap Innov’Est.
Read more news concerning Cap Innov'Est
Alsace Capital is a private equity general partner firm headquartered in Illkirch Graffenstaden, France.
View full profile
Registration is fast, free and easy
Already a member?